Mélanie Verreault
- Oncology top 10%
- Molecular Biology
- Pharmacology top 2%
- Surgery
- Epidemiology
- Co-authors
- Olivier BarbierJocelyn TrottierPatrick CaronJenny KaedingJulie BélangerPiotr MilkiewiczMartin PerreaultAlain Bélanger
- Topics
- Drug Transport and Resistance Mechanisms (16 papers)Pharmacogenetics and Drug Metabolism (13 papers)Liver Disease Diagnosis and Treatment (8 papers)
- Cited by
- PharmacologyOncologyHepatology
- Partner nations
- CanadaPolandUnited States
In The Last Decade
Mélanie Verreault
29 papers receiving 723 citations
Peers
Comparison fields: 5 of 86
- Oncology 324
- Molecular Biology 277
- Pharmacology 239
- Surgery 149
- Epidemiology 122
Countries citing papers authored by Mélanie Verreault
This map shows the geographic impact of Mélanie Verreault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Verreault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Verreault more than expected).
Fields of papers citing papers by Mélanie Verreault
This network shows the impact of papers produced by Mélanie Verreault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Verreault. The network helps show where Mélanie Verreault may publish in the future.
Co-authorship network of co-authors of Mélanie Verreault
This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Verreault. A scholar is included among the top collaborators of Mélanie Verreault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Verreault. Mélanie Verreault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 11 | |
| 3 | 11 | |
| 4 | 20 | |
| 5 | 13 | |
| 6 | 36 | |
| 7 | 12 | |
| 8 | 34 | |
| 9 | 40 | |
| 10 | 13 | |
| 11 | 38 | |
| 12 | 15 | |
| 13 | 21 | |
| 14 | 65 | |
| 15 | 25 | |
| 16 | 18 | |
| 17 | 29 | |
| 18 | 54 | |
| 19 | 103 | |
| 20 | 1 |
About Mélanie Verreault
Mélanie Verreault is a scholar working on Pharmacology, Oncology and Hepatology, having authored 31 papers that have together received 732 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (16 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Liver Disease Diagnosis and Treatment (8 papers). The work is most often cited by research in Pharmacology (239 citations), Oncology (324 citations) and Hepatology (49 citations). Mélanie Verreault has collaborated with scholars based in Canada, Poland and United States. Frequent co-authors include Olivier Barbier, Jocelyn Trottier, Patrick Caron, Jenny Kaeding, Julie Bélanger, Piotr Milkiewicz, Martin Perreault, Alain Bélanger, Marie‐Claude Vohl and Susan Grepper. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.